[{"address1": "9237 East Via de Ventura Boulevard", "address2": "Suite 105", "city": "Scottsdale", "state": "AZ", "zip": "85258", "country": "United States", "phone": "480 434 6670", "website": "https://journeymedicalcorp.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Zilxi, a topical minocycline treatment for inflammatory lesions; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lindsay Allan Rosenwald", "age": 68, "title": "Executive Chairman", "yearBorn": 1955, "fiscalYear": 2022, "totalPay": 50000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Claude  Maraoui", "age": 56, "title": "Founder, President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 820300, "exercisedValue": 0, "unexercisedValue": 2318750}, {"maxAge": 1, "name": "Mr. Joseph M. Benesch", "age": 56, "title": "Interim CFO & Corporate Controller", "yearBorn": 1967, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew J. Zwible", "title": "Vice President of Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ramsey  Alloush", "age": 37, "title": "General Counsel & Company Secretary", "yearBorn": 1986, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Nevin", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jaclyn  Jaffe", "title": "Senior Director of Corporate Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 5.43, "open": 5.22, "dayLow": 4.88, "dayHigh": 5.4034, "regularMarketPreviousClose": 5.43, "regularMarketOpen": 5.22, "regularMarketDayLow": 4.88, "regularMarketDayHigh": 5.4034, "payoutRatio": 0.0, "beta": 0.829, "forwardPE": -14.6470585, "volume": 423635, "regularMarketVolume": 423635, "averageVolume": 242652, "averageVolume10days": 504350, "averageDailyVolume10Day": 504350, "bid": 0.0, "ask": 0.0, "bidSize": 1000, "askSize": 800, "marketCap": 92171832, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 8.11, "priceToSalesTrailing12Months": 1.1537343, "fiftyDayAverage": 4.9146, "twoHundredDayAverage": 2.710685, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 70554080, "profitMargins": -0.15461001, "floatShares": 6891066, "sharesOutstanding": 12508400, "sharesShort": 174178, "sharesShortPriorMonth": 44605, "sharesShortPreviousMonthDate": 1700006400, "dateShortInterest": 1702598400, "sharesPercentSharesOut": 0.0094, "heldPercentInsiders": 0.35069, "heldPercentInstitutions": 0.17212, "shortRatio": 0.45, "shortPercentOfFloat": 0.0195, "impliedSharesOutstanding": 18508400, "bookValue": 0.939, "priceToBook": 5.3035145, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -12352000, "trailingEps": -0.69, "forwardEps": -0.34, "enterpriseToRevenue": 0.883, "enterpriseToEbitda": -34.551, "52WeekChange": 2.347719, "SandP52WeekChange": 0.24545836, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "DERM", "underlyingSymbol": "DERM", "shortName": "Journey Medical Corporation", "longName": "Journey Medical Corporation", "firstTradeDateEpochUtc": 1636727400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "60eabcee-8569-3738-9e3b-083fbc8348bc", "messageBoardId": "finmb_280596341", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.98, "targetHighPrice": 8.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.5, "targetMedianPrice": 7.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 24749000, "totalCashPerShare": 1.337, "ebitda": -2042000, "totalDebt": 3131000, "quickRatio": 0.675, "currentRatio": 0.921, "totalRevenue": 79890000, "debtToEquity": 18.021, "revenuePerShare": 4.44, "returnOnAssets": -0.04467, "returnOnEquity": -0.56715, "grossProfits": 42894000, "freeCashflow": 11459000, "operatingCashflow": 17924000, "revenueGrowth": 1.143, "grossMargins": 0.65248, "ebitdaMargins": -0.025559999, "operatingMargins": 0.49929002, "financialCurrency": "USD", "trailingPegRatio": null}]